Faculty profile
Laura Saward
Back to facultyResearch
Read how they describe their research on their University of Manitoba profile.
Latest papers
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.
Human vaccines & immunotherapeutics · 2022 · senior author
Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.
American journal of physiology. Heart and circulatory physiology · 2011
Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia.
The Journal of pharmacology and experimental therapeutics · 2008
3 publications.
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.
Tharmalingam T, Han X, Wozniak A, Saward L
Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.
Louis S, Saward L, Zahradka P
Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia.
Yau L, Molnar P, Moon MC, Buhay S, Werner JP, Molnar K, Saward L, Del Rizzo D, Zahradka P
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.